Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Vaccine
|
October 31, 2009
Comparative varicella vaccine effectiveness during outbreaks in day-care centres
M Spackova, M Wiese-Posselt, M Dehnert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1995
Pertussis in German adults
S Schmitt-Grohé, J D Cherry, U Heininger, et al.
Epidemiology and Infection
|
August 23, 2017
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data
K Bollaerts, M Riera-Montes, U Heininger, et al.
Molecular and Cellular Probes
|
September 4, 1998
Discrimination of Bordetella parapertussis and Bordetella pertussis organisms from clinical isolates by PCR using biotin-labelled oligonucleotide probes
F M Müller, U Heininger, N Schnitzler, et al.
Klinische Padiatrie
|
September 1, 1995
[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]
U Heininger, K Stehr, S Schmitt-Grohe, et al.
European Journal of Pediatrics
|
July 1, 1996
Bordetella pertussis infections and sudden unexpected deaths in children
U Heininger, K Stehr, G Schmidt-Schläpfer, et al.
The Pediatric Infectious Disease Journal
|
December 6, 2001
Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity
U Heininger, C Braun-Fahrländer, D Desgrandchamps, et al.
The Journal of Hospital Infection
|
November 9, 2011
Hospital-associated infections in children: a prospective post-discharge follow-up survey in three different paediatric hospitals
S Kinnula, M Buettcher, T Tapiainen, et al.
Vaccine
|
May 20, 2004
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
F Zepp, M Knuf, U Heininger, et al.
Infection
|
July 8, 2000
Optimal tobramycin dosage in patients with cystic fibrosis--evidence for predictability based on previous drug monitoring
K Bartel, T Habash, S Lugauer, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Vaccine
|
October 31, 2009
Comparative varicella vaccine effectiveness during outbreaks in day-care centres
M Spackova, M Wiese-Posselt, M Dehnert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 1995
Pertussis in German adults
S Schmitt-Grohé, J D Cherry, U Heininger, et al.
Epidemiology and Infection
|
August 23, 2017
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data
K Bollaerts, M Riera-Montes, U Heininger, et al.
Molecular and Cellular Probes
|
September 4, 1998
Discrimination of Bordetella parapertussis and Bordetella pertussis organisms from clinical isolates by PCR using biotin-labelled oligonucleotide probes
F M Müller, U Heininger, N Schnitzler, et al.
Klinische Padiatrie
|
September 1, 1995
[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]
U Heininger, K Stehr, S Schmitt-Grohe, et al.
European Journal of Pediatrics
|
July 1, 1996
Bordetella pertussis infections and sudden unexpected deaths in children
U Heininger, K Stehr, G Schmidt-Schläpfer, et al.
The Pediatric Infectious Disease Journal
|
December 6, 2001
Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity
U Heininger, C Braun-Fahrländer, D Desgrandchamps, et al.
The Journal of Hospital Infection
|
November 9, 2011
Hospital-associated infections in children: a prospective post-discharge follow-up survey in three different paediatric hospitals
S Kinnula, M Buettcher, T Tapiainen, et al.
Vaccine
|
May 20, 2004
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants
F Zepp, M Knuf, U Heininger, et al.
Infection
|
July 8, 2000
Optimal tobramycin dosage in patients with cystic fibrosis--evidence for predictability based on previous drug monitoring
K Bartel, T Habash, S Lugauer, et al.
Page
of 11